Ukko Revenue and Competitors
Estimated Revenue & Valuation
- Ukko's estimated annual revenue is currently $12.1M per year.
- Ukko's estimated revenue per employee is $155,000
- Ukko's total funding is $47.7M.
Employee Data
- Ukko has 78 Employees.
- Ukko grew their employee count by 7% last year.
Ukko's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | Chief Staff & Business Operations | Reveal Email/Phone |
3 | VP HR | Reveal Email/Phone |
4 | VP Development | Reveal Email/Phone |
5 | Sr. Director Protein Engineering and Target Discovery | Reveal Email/Phone |
6 | Director Project Management | Reveal Email/Phone |
7 | Director Business Development and Strategy | Reveal Email/Phone |
8 | Director Clinical Operations | Reveal Email/Phone |
9 | Employee Experience & HR Operations Manager | Reveal Email/Phone |
10 | Laboratory Operations Manager | Reveal Email/Phone |
Ukko Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31.6M | 198 | N/A | N/A | N/A |
What Is Ukko?
Ukko is improving the lives of millions that suffer from food allergies and disorders. We are using cutting edge technologies in immunology, computational biology, and plant science to develop a new approach. We have offices in Tel Aviv, Israel and Palo Alto, California.
keywords:N/A
$47.7M
Total Funding
78
Number of Employees
$12.1M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ukko News
In 2021-22, the Sabres had a revolving door that included stints from Ukko-Pekka Luukkonen, Michael Houser, Aaron Dell, and Malcolm Subban.
After rough stretch, Sabres prospect Ukko-Pekka Luukkonen thriving. ROCHESTER When Matthew Peca jumped off the bench, one-timed a rolling puck...
BUFFALO In assessing Ukko-Pekka Luukkonen's play, Sabres general manager Kevyn Adams looks beyond the suspect numbers the goalie prospect has compiled.
Ukko, a Tel Aviv, Israel-based biotech company with the mission to eliminate food allergies and sensitivities, raised $40m in Series B funding. The round was led by Leaps by Bayer, and was joined by Continental Grain Company, PeakBridge Ventures, Skyviews Life Science and Fall Line Capital, as ...
Ukko, a 30-employee biotech company using AI to investigate solutions for food allergies and sensitivities, today raised $40 million in a series B round led by Bayer’s Leaps by Bayer. Ukko says the new funding will allow it to enter clinical trials with an investigational therapeutic for peanut ...
Other Companies in Tel Aviv
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.9M | 78 | 5% | N/A |
#2 | $21.3M | 79 | 55% | N/A |
#3 | $11.1M | 79 | -9% | N/A |
#4 | $12.6M | 79 | 41% | N/A |
#5 | $16M | 79 | 20% | N/A |